The study found that Dios treatment reduced oxidative stress and pro-inflammatory factor secretion by regulating the nuclear factor erythroid-2-related factor 2 (Nrf2)/NF-κB/NOD-like receptor thermal protein domain associated protein 3 (NLRP3) pathway, thereby mitigating periodontitis [31]. The gene discussed is NFE2L2; the disease is periodontitis.